Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
January 03, 2023
Share
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received in Series B round of funding on January 4, 2023. The transaction included participation from new investors Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd. and Jointown Pharmaceutical Group Co., Ltd and other existing shareholders.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
JOINTOWN PHARMACEUTICAL GROUP CO., LTD 
